Interpreting Key Trials

Start all patients on statins early after PCI

The Lescol Intervention Prevention Study (LIPS)

Author and Disclosure Information

ABSTRACTThe Lescol Intervention Prevention Study (LIPS) was the first randomized trial to show a significant reduction in the risk of cardiac events in patients started on fluvastatin immediately after a successful percutaneous coronary intervention. The benefit was independent of baseline cholesterol levels. The results suggest that all patients should be discharged on lipid-lowering therapy after a percutaneous coronary intervention. Currently, this is seldom done.


Next Article:

Aggressive treatment of atherosclerosis: The time is now

Related Articles